explore -WSS

explore

author：Wikipedia 2025-09-28 01:38:05 - browse：43

Home health and hospice chain Amedisys has chosen a new corporate owner.

Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： STAT Virtual Event: The State of Biosimilars: What to Watch

WSS

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Close Medicare's dangerous gaps in addiction treatment coverage

MassMutual is introducing free genetic testing for members

H5N1 bird flu found in pasteurized milk: what we know

UnitedHealth financials solid despite Change Healthcare cyberattack

Medicare has a new plan to address drug shortages

entertainment

explore

focus

Jerome Adams on the need for new antivirals for Covid

Orangutan used medicinal plant to treat wound, first time ever seen

Alkermes shareholders re

Group opposing PBM reform sets lobbying record

Dobbs anniversary: the lost opportunity of abortion as health care

Cosmetics set for new safety regulation. Why the industry is on board

Virginia high school admissions case could be legal follow

Google and Epic fight stronger regulation of AI in health care

Trump demands the U.S. pay no more for drugs than other countries … again

Biden tests positive for Covid

entertainment

Sanofi seeks simpler, safer CRISPR sickle cell cure

Cue Health's Covid

Q&A: Jennifer Adair on making gene therapy available globally

At Orexo, a ‘turning point’ for everything but digital health

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Sanders adds drug shortage policies to pandemic preparedness bill

focus

focus

hotspot

hotspot